p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
CRISPR-Cas immunity in prokaryotes | Nature
The CRISPR tool kit for genome editing and beyond | Nature Communications
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
Beyond editing: repurposing CRISPR–Cas9 for precision genome regulation and interrogation | Nature Reviews Molecular Cell Biology
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors | Nature Biotechnology
Advances in CRISPR therapeutics | Nature Reviews Nephrology
CRISPR-based diagnostics | Nature Biomedical Engineering
Structural biology of CRISPR–Cas immunity and genome editing enzymes | Nature Reviews Microbiology
Cornerstones of CRISPR–Cas in drug discovery and therapy | Nature Reviews Drug Discovery
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
Occurrence and Nature of Off-Target Modifications by CRISPR-Cas Genome Editing in Plants | ACS Agricultural Science & Technology
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer | Nature Immunology
The kill-switch for CRISPR that could make gene-editing safer
The use of new CRISPR tools in cardiovascular research and medicine | Nature Reviews Cardiology
CRISPR-Cas3 induces broad and unidirectional genome editing in human cells | Nature Communications
Correction of a pathogenic gene mutation in human embryos | Nature
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy | Nature
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells | Nature
New CRISPR-based tool inserts large DNA sequences at desired sites in cells | MIT News | Massachusetts Institute of Technology
Controlling and enhancing CRISPR systems | Nature Chemical Biology
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
CRISPR in cancer biology and therapy | Nature Reviews Cancer
Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome | Nature Medicine
